Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
Background Therapeutic drug monitoring (TDM) of Vancomycin (VCM) is required to prevent inappropriate dosage-associated bacterial resistance, therapeutic failure, and toxicities in pediatrics. Anecdotal experience and studies show that many healthcare institutions confront barriers while implementin...
Saved in:
Main Authors: | Kashif Hussain (Author), Rahila Ikram (Author), Gul Ambreen (Author), Muhammad Sohail Salat (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible
by: Kashif Hussain, et al.
Published: (2022) -
Neurodevelopment Outcome of Neonates Treated With Intraventricular Colistin for Ventriculitis Caused by Multiple Drug-Resistant Pathogens-A Case Series
by: Kashif Hussain, et al.
Published: (2021) -
Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
by: Eric R. Gregory, et al.
Published: (2022) -
Vancomycin Prescribing Practices and Therapeutic Drug Monitoring for Critically Ill Neonatal and Pediatric Patients: A Survey of Physicians and Pharmacists in Hong Kong
by: Twinny Cheuk Hin Chow, et al.
Published: (2020) -
The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin-A Pilot Study
by: Paul Firman, et al.
Published: (2022)